6901 — Diamond Biofund Cashflow Statement
0.000.00%
- TWD34.18bn
- TWD27.55bn
- -TWD2.44bn
- 22
- 47
- 17
- 14
Annual cashflow statement for Diamond Biofund, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -371 | 6,091 | 2,961 | 881 | -2,584 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 304 | -6,500 | -3,062 | -1,005 | 2,452 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 16.6 | 133 | -211 | 586 | -2,446 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -39.6 | -263 | -300 | 473 | -2,568 |
Capital Expenditures | -1.48 | 0 | — | -2.05 | -19.5 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 61.2 | -115 | 115 | 4.53 | -7.12 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 59.8 | -115 | 115 | 2.48 | -26.6 |
Financing Cash Flow Items | — | — | — | — | 5.9 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -9.1 | -9.32 | -16.8 | -160 | 4,363 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 11.1 | -388 | -202 | 316 | 1,769 |